CA-125 IN PERITONEAL-FLUID FROM PATIENTS WITH ENDOMETRIOSIS

被引：8

作者：

MOEN, MH

HAGEN, B

ONSRUD, M

机构：

[1] Department of Obstetrics and Gynacology, National Hospital, University of Oslo, Oslo

[2] Department of Obstetrics and Gynaecology, University Hospital of Trondheim

来源：

HUMAN REPRODUCTION | 1991年 / 6卷 / 10期

关键词：

CA-125; DANAZOL; ENDOMETRIOSIS; PERITONEAL FLUID;

D O I：

10.1093/oxfordjournals.humrep.a137277

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

This study was performed to evaluate CA 125 in peritoneal fluid as an indicator of endometriosis. Peritoneal fluid from patients with mostly minimal and mild endometriosis (n = 43) and normal controls (n = 17) was collected at laparoscopy or laparotomy. The median concentration of CA 125 in peritoneal fluid did not differ significantly between patients and controls (79 IU/ml versus 76 IU/ml). In patients with endometriosis, a significantly increasing concentration of CA 125 in peritoneal fluid was seen from the early follicular to the late luteal phase; a similar change was not observed in the controls. In 14 patients, peritoneal fluid was sampled again after treatment with danazol and a significant reduction in median CA 125 concentration (76.5 IU/ml versus 57 IU/ml), peritoneal fluid volume (17.5 ml versus 10.5 ml) as well as reduced endometriosis scores (4 versus 2) were found. In controls, the concentration of CA 125 was about 10 times higher in peritoneal fluid than in serum. As the peritoneal levels of CA 125 did not differ significantly between patients with endometriosis and controls and as the reduction seen after danazol treatment did not correlate with the decrease of endometriotic implants, it is concluded that the monitoring of CA 125 in peritoneal fluid will not be useful in the diagnosis or control of endometriosis.

引用

页码：1400 / 1403

页数：4

共 26 条

[1]

Acien P., Shaw R.W., Irvine L., Burford G., Gardner R., CA 125 levels in endometriosis patients before, during and after treatment with Danazol or LHRH agonists, Eur. J. Obstel Gvnecol. Reprod. Biol, 32, pp. 241-246, (1989)

[2]

Revised American Society classification of endometriosis. Fertil, Steril., 43, pp. 351-352, (1985)

[3]

Barbieri R.L., Niloff J.M., Bast R.C., Schaetzl E., Kistner R.W., Knapp R.C., Elevated serum concentrations of CA-125 in patients with advanced endomariosis. Fertil, Steril., 45, pp. 630-634, (1986)

[4]

Bast R.C., Klug T.L., St John E., A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer, N. Engl. J. Med., 309, pp. 883-887, (1983)

[5]

Brumstedt J.R., McBean J.H., Deaton J.L., Gibson M., CA-125 secretion by luteal phase endometrium in vitro. Hum, Reprod., 5, pp. 682-684, (1990)

[6]

Dawood M.Y., Khan-Da Wood F.S., Ramos J., Plasma and peritoneal fluid levels of CA 125 in women with endometriosis, Am. J. Obstet. Cynecol, 159, pp. 1526-1531, (1988)

[7]

Eisermann J., Collins J.L., Enzyme immune assay determination of CA-125 in serum, peritoneal fluid, and follicular fluid from women with minimal endometriosis after ovarian hyperstimulation. Fend, Steril., 51, pp. 344-347, (1989)

[8]

Fedele L., Vercellini P., Arcaini L., Da Dalt M.G., Candiani G.B., CA 125 in serum, peritoneal fluid, active lesions, and endometrium with patients with endometriosis, Am. J. Obstet. Gynecol, 158, pp. 166-170, (1988)

[9]

Fisk N.M., Tan C.E., CA 125 in peritoneal fluid and serumof patients with endometriosis, Eur. J. Obstet. Gynecol. Reprod. Biol, 29, pp. 153-158, (1988)

[10]

Giirgan T., Serum and Peritoneal Fluid CA-125 Levels in Early Stage Endometriosis. Gynecol. Obstet. Invest., 30, pp. 105-108, (1990)

← 1 2 3 →